Plasma therapy or convalescent plasma therapy is one of the most popular and constructive methods to boost the immune system. It involves use of blood from a person who has recently recovered from an illness to donate it to someone who is currently suffering from the same disease. This blood is likely to contain antibodies that are essential to fight the illness, especially when the patient’s immune system is not positively responding.
According to Allied Market Research, the global plasma therapy market is projected to reach $698.46
million by 2030, registering a CAGR of 8.5% from 2021 to 2030. The surge in the
geriatric population and prevalence of rare diseases, the rise in the number of
androgenic alopecia patients, and increase in the number of plasma collection
centers drive the growth of the market.
The use of plasma therapy has proven to be
effective for back pain and dermatological treatment. As this method of
treatment is considered to be much safer, the use of plasma therapy for orthopedic
illnesses and skin diseases has increased drastically. The therapy is less
painful, causes less thermal damage and bleeding during the process, and
improves the recovery period considerably. More importantly, it poses no risk
of transurethral resection (TUR) syndrome and other side effects.
Platelet-rich plasma (PRP) therapy gained
traction for dealing with skin diseases. The treatment gained popularity as a “vampire
facial” as it used plasma from other patients to stimulate skin regeneration. People
who are more concerned about injecting foreign chemicals into their bodies
prefer to undergo plasma therapy, especially treating hair regeneration and
acne scarring. What’s more, PRP therapy can stimulate hair growth cells and
help gain thicker hair over time.
Apart from the treatment of skin diseases, plasma
therapy to treatment of the orthopedic condition is considered to be one of the
rapidly-evolving branches of science. Several clinical results show that PRP is
a more promising method to treat soft tissues and bone-related injuries
compared to traditional methods. Now, plasma therapy is recommended to treat
various conditions such as rotator cuff injury, Achilles tendinopathy, and lateral
epicondylitis.
Impact of COVID-19 Pandemic on the Plasma Therapy Market
Plasma
from the blood of a patient who recovered from the COVID-19 was used for
treatment of another patient suffering from COVID-19. Convalescent plasma can
potentially develop as an effective treatment option to battle against the
pandemic. Thus, rise in demand for plasma derived immunoglobulins for treatment
procedures for COVID-19 patients with autoimmune and inflammatory disorders,
which is anticipated to drive growth of the plasma fractionation market for
immunoglobulin.
Plasma therapy is used for treatment of many disorders such
as hair loss, tendon injuries, acute injuries, post-surgical repair, and
osteoarthritis and currently for treatment of COVID–19. Furthermore, several
manufacturers are initiating plasma processing to tackle the spread of
coronavirus across the world. Therefore, the global plasma therapy market is
expected to witness significant growth during the forecast period.
During the Covid-19 outbreak, plasma therapy was used. Until
researchers could find a vaccine or proper method of treatment for a novel
viral infection, plasma therapy offers the best chance to fight the disease. However,
plasma therapy still needs the support of clinical trials for its widespread
use, they have proven to be effective in treating chronic illness. Thus, in the
future, more companies would invest in clinical trials and make it an ideal
method of treatment for fighting novel infections or outbreaks.
0 Comments